Skip to main content
. 2020 Sep 4;10:1690. doi: 10.3389/fonc.2020.01690

FIGURE 10.

FIGURE 10

Immunogenic treatment with mEHT. The induced immunogenic cell-death presents the genetic information to DCs forming antigen presenting cells (APCs) and tumor-specific killer cells which are active all over the system. It is an in situ, real-time process.